Baldwin D. Room for Improvement in the Pharmacological Treatment of Anxiety Disorders. Current Pharmaceutical Design. 2008;14(33):3482–91.
2.
Bystritsky A, Khalsa SS, Cameron ME, Schiffman J. Current diagnosis and treatment of anxiety disorders. P T. 2013;38:30–57.
3.
McCall JG, Siuda ER, Bhatti DL, Lawson LA, McElligott ZA, Stuber GD, et al. Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior. eLife. 6.
4.
Ahissar E, Oram T. Thalamic Relay or Cortico-Thalamic Processing? Old Question, New Answers. Cerebral Cortex. 2015;25(4):845–8.
5.
Lee S, Shin HS. The role of mediodorsal thalamic nucleus in fear extinction. Journal of Analytical Science and Technology. 2016;7(1).
6.
Garcia-Rill E, Kezunovic N, Hyde J, Simon C, Beck P, Urbano FJ. Coherence and frequency in the reticular activating system (RAS). Sleep Medicine Reviews. 2013;17(3):227–38.
7.
Anxiety Disorders. 2010.
8.
Baldwin DS, In BE. The Wiley Handbook of Anxiety Disorders. 2014.
9.
Thibaut F. Anxiety disorders: a review of current literature. Dialogues in Clinical Neuroscience. 2017;19(2):87–8.
10.
Liberzon I, Duval E, Javanbakht A. Neural circuits in anxiety and stress disorders: a focused review. Therapeutics and Clinical Risk Management. :115.
11.
Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues in Clinical Neuroscience. 2017;19(2):93–107.
12.
Muscatello MR, Spina E, Bandelow B, Baldwin DS. Clinically relevant drug interactions in anxiety disorders. Human Psychopharmacology: Clinical and Experimental. 2012;27(3):239–53.
13.
Hanson C, Modiba W. Overview and management of anxiety disorders. S Afr Pharm J. 2017;84:43–50.
14.
Nutt DJ. Overview of Diagnosis and Drug Treatments of Anxiety Disorders. CNS Spectrums. 2005;10(1):49–56.
15.
Katzung B, Masters SB, Trevor AJ. Basic and Clinical Pharmacology. 2012.
16.
Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D. Early Coadministration of Clonazepam With Sertraline for Panic Disorder. Archives of General Psychiatry. 2001;58(7):681.
17.
Sarris J. Herbal medicines in the treatment of psychiatric disorders: 10‐year updated review. Phytotherapy Research. 2018;32(7):1147–62.
18.
Yeung KS, Hernandez M, Mao JJ, Haviland I, Gubili J. Herbal medicine for depression and anxiety:<scp>A</scp>systematic review with assessment of potential psycho‐oncologic relevance. Phytotherapy Research. 2018;32(5):865–91.
19.
Blaustein JD. Handbook of Neurochemistry and Molecular Neurobiology: Behavioral Neurochemistry, Neuroendocrinology and Molecular Neurobiology. 2006.
20.
Craig KJ, Brown KJ, Baum A. Environmental factors in the etiology of anxiety. In: Psychopharmacology: the Fourth Generation of Progress. 1995. p. 1325–39.
21.
Shin LM, Liberzon I. The Neurocircuitry of Fear, Stress, and Anxiety Disorders. Neuropsychopharmacology. 2010;35(1):169–91.
22.
straha SVB, strahu, fobiji. Mladost Biro. 2005;
23.
Morris LW, Davis MA, Hutchings CH. Cognitive and emotional components of anxiety: Literature review and a revised worry–emotionality scale. Journal of Educational Psychology. 73(4):541–55.
24.
Nešić M. Pshichoneuroendocrino-immunology of stress, Faculty of Medicine, Niš, Serbia 2005.
25.
Barlow DH. Unraveling the mysteries of anxiety and its disorders from the perspective of emotion theory. American Psychologist. 55(11):1247–63.
26.
Barlow DH. Anxiety and its disorders: The nature and treatment of anxiety and panic. 1988.
27.
Gelenberg AJ. Psychiatric and Somatic Markers of Anxiety. The Primary Care Companion For CNS Disorders. 2(2).
28.
Steimer T. The biology of fear- and anxiety-related behaviors. Dialogues in Clinical Neuroscience. 2002;4(3):231–49.
29.
Mayer EA. Gut feelings: the emerging biology of gut–brain communication. Nature Reviews Neuroscience. 2011;12(8):453–66.
30.
Emond M, Schwartz GJ, Moran TH. Meal-related stimuli differentially induce c-Fos activation in the nucleus of the solitary tract. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2001;280(5):R1315–21.
31.
Stern T, Fricchione G, Rosenbaum J. Massachusetts General Hospital Handbook of General Hospital Psychiatry. 2010.
32.
Remes O, Brayne C, van der Linde R, Lafortune L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain and Behavior. 2016;6(7).
33.
Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues in Clinical Neuroscience. 2015;17(3):327–35.
34.
Stojanović NM, Samardžić L, Randjelović PJ, Radulović NS. Prevalence of self-medication practice with herbal products among non-psychotic psychiatric patients from southeastern Serbia: A cross-sectional study. Saudi Pharmaceutical Journal. 2017;25(6):884–90.
35.
Bourin M. Animal models for screening anxiolytic-like drugs: a perspective. Dialogues in Clinical Neuroscience. 2015;17(3):295–303.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
